Rapamycin protects dopaminergic neurons against rotenone-induced cell death in primary mesencephalic cell culture
Open accessAbstract
INTRODUCTION: Parkinson's disease is the most common movement disorder, characterized by a progressive and extensive loss of dopaminergic neurons in the substantia nigra pars compacta and their terminals in the striatum. So far, only symptomatic treatment is available, and no cure or disease-modifying drugs exist. The present study was designed to investigate the neuroprotective effect of rapamycin, an autophagy inducer, on dopaminergic neurons against rotenone-induced cell death in primary mesencephalic cell culture. MATERIAL AND METHODS: Primary mesencephalic cell cultures were prepared from embryonic mouse mesencephala (OFI/SPF, Vienna, Austria) at gestation day 14. Four sets of cultures were treated as follows: one was run as an untreated control, a second one was treated with 20 nM rotenone on the 10th day in vitro (DIV) for 48 h, a third one was co-treated with 20 nM rotenone and rapamycin (1, 10, 100, 1000 nM) on the 10th DIV for 48 h, and a fourth one was treated with rapamycin alone (1, 10, 100, 1000 nM) on the 10th DIV for 48 h. On the 12th DIV, cultures were subjected to immunohistochemistry against tyrosine hydroxylase and to fluorescence staining using LysoTracker Deep Red, JC-1 and DAPI stains. RESULTS: Exposure of such cultures to 20 nM rotenone on the 10th DIV for 48 h reduced the number of dopaminergic neurons by 41% and increased the release of lactate dehydrogenase (LDH) by 178% above untreated controls. Rapamycin (1, 10, 100, 1000 nM) added together with rotenone from the 10th to 12th DIV spared dopaminergic neurons by 17% and reduced the release of LDH by 64% at the concentration of 100 nM compared to rotenone-treated cultures. Activation of an autophagic process by rapamycin was demonstrated by LysoTracker Deep Red fluorescent dye, as indicated by a shift to increased red fluorescence. Rapamycin also significantly elevated the mitochondrial membrane potential (Δψm), as shown by an increase of the red:green fluorescence ratio of JC-1. Increased apoptotic cell death due to rotenone was lowered by rapamycin, as shown by the blue-fluorescent DAPI nucleic acid stain. CONCLUSIONS: Our study indicates for the first time that rapamycin, known as an autophagy inducer, protected dopaminergic neurons against rotenone-induced cell death in primary mesencephalic cell culture.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Rapamycin protects primary murine mesencephalic cells against rotenone-induced cell death and is accompanied by an increase in mitochondrial potential membrane.
“Interestingly, rapamycin treatment is accompanied by an increase in mitochondrial potential membrane [100], suggesting, again, a link between mitochondrial (un)coupling and autophagy.”
From Mitochondrial Uncoupling: A Key Controller of Biological Processes in Physiology and Diseases (2019) · cites this paper as [100]
The citation lists haven’t been fetched yet
References 31 · Cited by 24
- Authors
- Radad, K., Moldzio, R., & Rausch, W.-D.
- Affiliations
- Assiut University (EG)
- University of Veterinary Medicine Vienna (AT)
- Corresponding author
- Radad, Khaled
- Venue
- Folia Neuropathologica
- Publisher
- Termedia Sp. z.o.o.
- Published
- 2015
- Volume
- 3
- Issue
- 3
- Pages
- 250-261
- ISSN
- 1509-572X (ISSN-L)
- 1641-4640
- OpenAlex
- W2410861866
- Cited by
- 24
- References
- 31
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 1 · 2023: 1 · 2021: 2 · 2020: 3 · 2019: 4 · 2018: 3 · 2017: 5 · 2016: 1
- FWCI
- 2.11
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Licence
- cc-by-nc-sa
- Locations
- Folia Neuropathologica (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Neurology › Parkinson's Disease Mechanisms and Treatments
- Health Sciences › Medicine › Epidemiology › Autophagy in Disease and Therapy
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nuclear Receptors and Signaling
- Keywords
- rapamycin, neuroprotection, dopaminergic neurons, rotenone, Parkinson's disease, autophagy, mitochondrial membrane potential, mitochondrial depolarization, apoptosis, tyrosine hydroxylase, lactate dehydrogenase release, autophagy induction, mitochondrial dysfunction, substantia nigra pars compacta, striatum, disease-modifying therapy
- MeSH terms
- Animals, Cells, Cultured, Immunosuppressive Agents, Mesencephalon, Parkinson Disease, Rotenone, Uncoupling Agents, Apoptosis, Neuroprotective Agents, Sirolimus, Mice, Dopaminergic Neurons
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review